$9.2 - ALGS | Aligos Therapeutics, Inc. Common Stock

Aligos Therapeutics, Inc. Common Stock (ALGS)

Aligos Therapeutics, Inc. Common Stock

XNAS:ALGS

9.2

-3.97%

Ask

$11.16 - 100.00

Bid

$8.70 - 60.00

Low

$9.18

High

$9.92

Open

$9.37

Prev Close

$9.58

52W High

46.8

52W Low

3.76

Volume

114285

Avg Vol (3m)

86819.8

Float

4713190.11

Chart

TendieTensor AI Analysis

Company

Asset Type: Common Stock

SIC Code: 2836

Sector: Health Technology

Industry: Pharmaceuticals: Major

Date Listed: 10/16/2020

Primary Exchange: XNAS

Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.

Phone: (800) 466-6059

Address: One Corporate Dr., 2nd Floor

City: South San Francisco

State: CA

Postal Code: 94080

Website

TendieTensor AI Analyst Recommendation: —

Fundamentals

Total Employees:

P/E (TTM)

-0.470000

P/B (TTM)

0.820662

EPS

-3.04

Round Lot

100

Composit FIGI

BBG00QX7QH68

Share Class FIGI

BBG00QX7QH77

Share Class Shares Outstanding

5.35M

Weighted Shares Outstanding

6.95M

Technicals

RSI (14)

MACD Line

MACD Signal

SMA 20

SMA 50

EMA 50

Trend

Short Interest

—

Days to Cover

— —

Higher = harder to cover

Short Interest Δ

—

Prev: —

Short Volume Ratio (Today)

— —

5D avg: —

Squeeze Score (0–100)

—

Discussion